Drugs / C2101
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06816719 | Sep → Nov 2024 | — | JW Pharmaceutical | Completed | No outcome recorded |
| Phase 1 | NCT06355349 | Apr → Jul 2023 | — | JW Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C2101 | “Reference Drug(JW0101 and C2101) or Test Drug(JW0102)” NCT06355349 ↗ |
| Route | Oral | “Tablet, Oral, QD for 1 Day” NCT06355349 ↗ |